0
Lab Reports |

Lupus Antibodies Fight Cancer

Tracy Hampton, PhD
JAMA. 2012;308(22):2326. doi:10.1001/jama.2012.111747.
Text Size: A A A
Published online

Extract

Lupus antibodies not only react against host DNA, they also may make cancer cells more sensitive to treatment. A new study has found that a lupus antibody called 3E10 sensitizes ovarian tumors to radiation by penetrating and binding to DNA within tumor cells, impairing DNA repair mechanisms (Hansen JE et al. Sci Transl Med. 2012;4[157]:157ra142). This makes the tumor cells more vulnerable to DNA-damaging therapies.

The antibody itself could also kill cancer cells deficient in DNA repair. It has already been deemed safe in a human clinical trial, where it was tested as a possible vaccine for lupus.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Idelalisib--a PI3Kd inhibitor for B-cell cancers. N Engl J Med 2014;370(11):1061-2.
Laboratory diagnosis of human papillomavirus infection. Curr Probl Dermatol 2014;45():166-74.
Jobs
JAMAevidence.com

The Rational Clinical Examination
Make the Diagnosis: Cancer, Family History

The Rational Clinical Examination
Original Article: Does This Patient Have a Family History of Cancer?

brightcove.createExperiences();